Business Development

Collaborative Drug Discovery

Cyclenium offers access to its proprietary CMRT drug discovery technology, QUEST Library, extensive expertise and broad experience directed towards partner's targets of interest:

  • Macrocycle-based drug discovery and development including hit validation, lead optimization, generation of clinical candidates, preclinical and clinical development
  • Design and construction of targeted libraries starting from HTS, peptide leads or known protein-ligand interactions
  • Creation of custom-designed macrocycles for addition to corporate screening collections
  • Process research and development support for macrocycle scale-up and manufacturing
  • Customer-focused design of macrocycle-based R&D programs

These are only examples of the types of collaborative efforts in which the Cyclenium team has expertise and that can be applied to have a positive impact on partner programs.

Out-Licensing

Cyclenium is seeking partners with interest in the development of its advanced lead programs:

  • Broad spectrum anti-flaviviral agents
  • Novel target strategy for the treatment of cystic fibrosis
  • Biased opioid agonists for use in pain or CNS disorders

To obtain additional information on these or any of our active projects, please contact Cyclenium.

In-Licensing

Cyclenium also welcomes inquiries from researchers with interesting early stage product development opportunities, particularly in the fields of oncology, anti-infectives, inflammatory disorders and pain.

Please contact Cyclenium to arrange for further discussions.